跳至主要内容
临床试验/IRCT20130418013058N12
IRCT20130418013058N12招募中2 期

Pilot Study on the effectiveness of crocin as a drug supplement in the treatment of ocular complications of Behcet's disease; a clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • A patient with active Behcet's with ocular complications is selected according to the sun criteria,
  • Patients with Behcet's syndrome with anterior, posterior, or diffuse eye involvement
  • Long-term illness of the eye with active retinal vasculitis and macular edema
  • Age over 18 years of both sexes
  • A patient with Behcet's who is resistant (without improvement or exacerbation of the eye disease) or an approximate response (mild to moderate) to combination therapy (Psychosis and Steroids drugs)
  • The ability to understand the overall study, interventions and possible complications

排除标准

  • Patients with bilateral vision loss
  • Patients receiving anti-TNF drugs such as thalidomide and pentoxifylline in the past three months.
  • Patients with a history of immunosuppression include a viral infection such as tuberculosis
  • Severe viral infections including hepatitis, pneumonia, pyelonephritis, or hepatitis in the last three months
  • Pregnancy and breastfeeding
  • Sensitivity to saffron
  • alcohol consumption
  • Cataract and other general items

研究者

相似试验